These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3130631)

  • 1. Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.
    Gaffney PJ; Urano T; de Serrano VS; Mahmoud-Alexandroni M; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3595-8. PubMed ID: 3130631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator.
    Urano T; Sator de Serrano V; Gaffney PJ; Castellino FJ
    Biochemistry; 1988 Aug; 27(17):6522-8. PubMed ID: 3146348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase.
    Urano T; Chibber BA; Castellino FJ
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4031-4. PubMed ID: 3473492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of human plasminogen activation.
    Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
    Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR; Gardell SJ
    Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation.
    Menhart N; Hoover GJ; McCance SG; Castellino FJ
    Biochemistry; 1995 Feb; 34(5):1482-8. PubMed ID: 7849007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.
    de Serrano VS; Urano T; Gaffney PJ; Castellino FJ
    J Protein Chem; 1989 Feb; 8(1):61-77. PubMed ID: 2527513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of human [Glu1]plasminogen by human single-chain urokinase.
    Urano T; de Serrano VS; Gaffney PJ; Castellino FJ
    Arch Biochem Biophys; 1988 Jul; 264(1):222-30. PubMed ID: 2456035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of individual kringle domains toward maintenance of the chloride-induced tight conformation of human glutamic acid-1 plasminogen.
    McCance SG; Castellino FJ
    Biochemistry; 1995 Jul; 34(29):9581-6. PubMed ID: 7626628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the streptokinase-catalyzed activation of human plasminogen by human fibrinogen and its plasminolysis products.
    Strickland DK; Morris JP; Castellino FJ
    Biochemistry; 1982 Feb; 21(4):721-8. PubMed ID: 7200372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.
    Gurewich V; Pannell R
    Thromb Haemost; 2009 Aug; 102(2):279-86. PubMed ID: 19652878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
    Ries M; Klinge J; Rauch R; Keuper H; Harms D
    Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
    Kruithof EK; Schleuning WD
    Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.